The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 9,338 | 4,059,894 | SH | SOLE | 4,059,894 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 34,273 | 1,177,374 | SH | SOLE | 1,177,374 | 0 | 0 | ||
AMAZON COM INC | COM | 023135106 | 147,095 | 45,122 | SH | SOLE | 45,122 | 0 | 0 | ||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 6,146 | 1,491,832 | SH | SOLE | 1,491,832 | 0 | 0 | ||
AMERISOURCEBERGEN CORP | COM | 03073E105 | 59,275 | 383,138 | SH | SOLE | 383,138 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 21,493 | 1,533,059 | SH | SOLE | 1,533,059 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 4,268 | 344,755 | SH | SOLE | 344,755 | 0 | 0 | ||
BATH & BODY WORKS INC | COM | 070830104 | 49,647 | 1,038,630 | SH | SOLE | 1,038,630 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,974 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BENITEC BIOPHARMA INC | COM | 08205P100 | 1,796 | 769,000 | SH | SOLE | 769,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 7,308 | 61,631 | SH | SOLE | 61,631 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 6,111 | 2,230,250 | SH | SOLE | 2,230,250 | 0 | 0 | ||
CANO HEALTH INC | *W EXP 06/03/202 | 13781Y111 | 1,065 | 674,066 | SH | SOLE | 674,066 | 0 | 0 | ||
CANO HEALTH INC | COM CL A | 13781Y103 | 23,295 | 3,668,478 | SH | SOLE | 3,668,478 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 100,793 | 1,197,206 | SH | SOLE | 1,197,206 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 12,671 | 2,766,619 | SH | SOLE | 2,766,619 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 23,464 | 1,434,200 | SH | SOLE | 1,434,200 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 68,220 | 232,570 | SH | SOLE | 232,570 | 0 | 0 | ||
DECIBEL THERAPEUTICS INC | COM | 24343R106 | 801 | 263,600 | SH | SOLE | 263,600 | 0 | 0 | ||
DECKERS OUTDOOR CORP | COM | 243537107 | 39,006 | 142,477 | SH | SOLE | 142,477 | 0 | 0 | ||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 995 | 106,000 | SH | SOLE | 106,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 984 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 6 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
EUROPEAN BIOTECH ACQUTN CORP | *W EXP 03/06/202 | G3167F128 | 20 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
EUROPEAN BIOTECH ACQUTN CORP | CLASS A ORD SHS | G3167F102 | 2,922 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 35,349 | 2,909,407 | SH | SOLE | 2,909,407 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | CL A SHS | G3710A105 | 860 | 87,498 | SH | SOLE | 87,498 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 7 | 29,166 | SH | SOLE | 29,166 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 61,807 | 2,613,412 | SH | SOLE | 2,613,412 | 0 | 0 | ||
GEMINI THERAPEUTICS INC | COM | 36870G105 | 3,297 | 2,372,267 | SH | SOLE | 2,372,267 | 0 | 0 | ||
GFL ENVIRONMENTAL INC | SUB VTG SHS | 36168Q104 | 74,337 | 2,284,496 | SH | SOLE | 2,284,496 | 0 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 16,411 | 2,869,048 | SH | SOLE | 2,869,048 | 0 | 0 | ||
HILTON WORLDWIDE HLDGS INC | COM | 43300A203 | 55,037 | 362,703 | SH | SOLE | 362,703 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 82,198 | 188,888 | SH | SOLE | 188,888 | 0 | 0 | ||
IMMUNEERING CORP | CLASS A COM | 45254E107 | 1,294 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 6,012 | 3,285,000 | SH | SOLE | 3,285,000 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 4,144 | 1,013,216 | SH | SOLE | 1,013,216 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 30,983 | 1,318,432 | SH | SOLE | 1,318,432 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 93,738 | 1,531,923 | SH | SOLE | 1,531,923 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 6,763 | 406,200 | SH | SOLE | 406,200 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 89,411 | 386,710 | SH | SOLE | 386,710 | 0 | 0 | ||
JOHNSON & JOHNSON | COM | 478160104 | 73,605 | 415,310 | SH | SOLE | 415,310 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 25,740 | 1,746,300 | SH | SOLE | 1,746,300 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 23,433 | 1,409,956 | SH | SOLE | 1,409,956 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 62,600 | 3,893,019 | SH | SOLE | 3,893,019 | 0 | 0 | ||
LAS VEGAS SANDS CORP | COM | 517834107 | 88,440 | 2,275,282 | SH | SOLE | 2,275,282 | 0 | 0 | ||
LAUDER ESTEE COS INC | CL A | 518439104 | 101,432 | 372,475 | SH | SOLE | 372,475 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 25,862 | 2,766,000 | SH | SOLE | 2,766,000 | 0 | 0 | ||
MARQETA INC | CLASS A COM | 57142B104 | 44,711 | 4,049,950 | SH | SOLE | 4,049,950 | 0 | 0 | ||
MARRIOTT INTL INC NEW | CL A | 571903202 | 54,349 | 309,240 | SH | SOLE | 309,240 | 0 | 0 | ||
MASTERCARD INCORPORATED | CL A | 57636Q104 | 68,239 | 190,943 | SH | SOLE | 190,943 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 29,995 | 97,980 | SH | SOLE | 97,980 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 479 | 34,600 | SH | SOLE | 34,600 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 10,239 | 9,142,067 | SH | SOLE | 9,142,067 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 183,675 | 595,747 | SH | SOLE | 595,747 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 41,959 | 510,331 | SH | SOLE | 510,331 | 0 | 0 | ||
MOLECULAR PARTNERS AG | ADS | 60853G106 | 8,220 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 23,784 | 584,660 | SH | SOLE | 584,660 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 2,946 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | UNIT 09/22/2026 | 671005205 | 1,999 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 2,353 | 440,696 | SH | SOLE | 440,696 | 0 | 0 | ||
OTIS WORLDWIDE CORP | COM | 68902V107 | 99,841 | 1,297,480 | SH | SOLE | 1,297,480 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 7,546 | 3,144,196 | SH | SOLE | 3,144,196 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 15,007 | 827,540 | SH | SOLE | 827,540 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 24,025 | 3,014,408 | SH | SOLE | 3,014,408 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 4,885 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
RH | COM | 74967X103 | 59,295 | 181,835 | SH | SOLE | 181,835 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 3,367 | 681,528 | SH | SOLE | 681,528 | 0 | 0 | ||
ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 78,918 | 2,025,610 | SH | SOLE | 2,025,610 | 0 | 0 | ||
S&P GLOBAL INC | COM | 78409V104 | 84,809 | 206,760 | SH | SOLE | 206,760 | 0 | 0 | ||
SCHWAB CHARLES CORP | COM | 808513105 | 82,859 | 982,790 | SH | SOLE | 982,790 | 0 | 0 | ||
SELECT SECTOR SPDR TR | ENERGY | 81369Y506 | 52,963 | 692,868 | SH | SOLE | 692,868 | 0 | 0 | ||
SIO GENE THERAPIES INC | COMMON | 829399104 | 3,962 | 5,914,000 | SH | SOLE | 5,914,000 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 8,670 | 7,224,860 | SH | SOLE | 7,224,860 | 0 | 0 | ||
SPDR SER TR | S&P OILGAS EXP | 78468R556 | 22,197 | 164,970 | SH | SOLE | 164,970 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 30,680 | 3,732,400 | SH | SOLE | 3,732,400 | 0 | 0 | ||
TAPESTRY INC | COM | 876030107 | 86,192 | 2,320,100 | SH | SOLE | 2,320,100 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 3,679 | 1,238,800 | SH | SOLE | 1,238,800 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 67,966 | 115,069 | SH | SOLE | 115,069 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 1,970 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 22 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 38,133 | 525,100 | SH | SOLE | 525,100 | 0 | 0 | ||
UNION PAC CORP | COM | 907818108 | 167,649 | 613,628 | SH | SOLE | 613,628 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 122,901 | 240,997 | SH | SOLE | 240,997 | 0 | 0 | ||
VISA INC | COM CL A | 92826C839 | 97,133 | 437,990 | SH | SOLE | 437,990 | 0 | 0 | ||
WYNN RESORTS LTD | COM | 983134107 | 29,190 | 366,060 | SH | SOLE | 366,060 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 21,154 | 692,000 | SH | SOLE | 692,000 | 0 | 0 |